AI-generated discussions on the latest tech and AI news. Every article gets a unique podcast episode.
807
Episodes
13+
Hours of content
Cytology helps detect cancer early but is subjective. A new AI system automates the process, achieving high accuracy in cervical cancer screening and enabling objective, scalable diagnostics.
New photonics system enables 512 Gbps fiber and 400 Gbps wireless using same hardware, supporting ultra-dense, high-speed networks.
New glass-based optical storage uses lasers to write data, achieving high density and durability for long-term archival, with potential data lifetimes over 10,000 years.
The brain's dural sinuses are active, not passive, veins. They dynamically regulate blood flow, fluid exchange, and immune cell surveillance, which is crucial for antiviral defense.
A protein called GPNMB and its receptor RYK drive fatty liver disease (MASH) in mice and humans. Blocking this pathway with various treatments effectively prevented and treated MASH in animal models, identifying a promising new therapeutic target.
A new base-editing therapy corrected a mutation in mice modeling a neurodevelopmental disorder, restoring protein levels and improving symptoms, with promising results in primates.
Cryo-EM shows microtubules drive assembly of a dynein-dynactin motor complex, while adaptors can later join. LIS1 regulator stabilizes intermediates, priming the machinery for transport.
The brain uses complex mRNA translation regulation. A new method, Ribo-STAMP, created the first isoform-sensitive, single-cell translatomes of the mouse hippocampus. It revealed thousands of cell-type-specific translated transcripts and differential translation states in neurons, advancing understanding of brain function and disease.
A genetic variant reduces CCND3 expression in red blood cells, increasing their size and decreasing their number. This impairs malaria parasite growth via reactive oxygen species, revealing a protective mechanism.
An mRNA vaccine targeting neoantigens induced strong, long-lasting T cell responses in triple-negative breast cancer patients. Most remained cancer-free for years, with insights into why a few relapsed.